SENS-501
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SENS-501, covering 2024-09-26 to 2024-09-26. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II Clinical Trial with SENS-501 in Children Suffering from Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations [Phase 1, Phase 2]